€
1. 88
+0.05
+2.7293%
€
116.06M Market Cap
- P/E Ratio
- Div Yield
1,800 Volume
-0.18 Eps
€ 1.83
Previous Close Want to track 609 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abionyx Pharma SA (609) Statistics
Valuation metrics
Market Cap 116.06M
Enterprise value 116.35M
Trailing P/E (ttm) -21.16
Forward P/E -
PEG ratio -
Price/Sales (ttm) 28.31
Price/Book (mrq) 21.56
Enterprise Value/Revenue 28.64
Enterprise Value/EBITDA -22.43
Overview
Shares outstanding 35.29M
Float -
Shares short -
% Held by insiders 0.36%
% Held by institutions 0.04%
Average volume (10 days) 632
Average volume (90 days) 714
Price summary
52-Week low 1.54
52-Week high 5
Beta 0.67
50-Day moving average 3.41
200-Day moving average 3.4
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.34%
Operating margin -1.6%
Operational effectiveness
Return on assets -0.42%
Return on equity -1.23%
Income Statement
Revenue (ttm) 4.1M
Revenue per share (ttm) 0.12
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 600K
EBITDA -5.38M
Net income to common (ttm) -5.5M
Diluted EPS (ttm) -0.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 3.52M
Total cash per share (mrq) -
Total debt (mrq) 3.81M
Total Debt/Equity (mrq) 0.84
Current ratio (mrq) 1.06%
Book value per share (mrq) 0.16
Cash Flow
Cash flow statement -2.9M
Levered free cash flow (LFCF) -5.55M
